Johnson & Johnson Innovative Medicine, the pharmaceutical division of Johnson & Johnson, was reportedly affected by a data breach on May 4, 2026. This information comes from a ransomware tracking site.
The specific types of data exposed, the number of individuals affected, and the states impacted have not been publicly confirmed. There is no evidence currently available to indicate that this was a vendor or third-party breach.
Details can emerge later as investigations progress, and official notices may be delayed.